neo-gambogic acid has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Hu, RF; Li, QL; Su, JJ; Wang, YL | 1 |
| Chen, L; Fan, Y; He, S; Nie, C; Peng, A; Shao, X | 1 |
2 other study(ies) available for neo-gambogic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Mechanism of gambogenic acid in resisting angiogenesis of lung cancer in vitro].
Topics: A549 Cells; Apoptosis; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Transfection; Xanthenes | 2018 |
Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelium, Vascular; Female; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Plant Extracts; Plants, Medicinal; Proto-Oncogene Proteins c-akt; rho GTP-Binding Proteins; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xanthenes; Xanthones; Xenograft Model Antitumor Assays; Zebrafish | 2013 |